NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: University Hospital, Bordeaux
Conditions: Asthma
Interventions: anharmonic morphological analysis of the respiratory signals (AMARS)
Countries: France
Asthma exacerbations account for a significant morbidity and disproportionate health care costs. However, there is no currently available biomarker or lung function parameter that can accurately predict the risk of future exacerbations. The current work aims at evaluating the resting ventilatory flow by applying a new technique called anharmonic morphological analysis of the respiratory signals (AMARS). We hypothesize that monitoring AMARS is potentially able to detect an increased risk of asthma exacerbations.
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Inclusion Criteria: * male or female aged more than 18 yrs * written informed consent * diagnosis of asthma according to Global Initiative For Asthma (GINA) criteria * history of at least one moderate to severe exacerbation in the previous 12 months Exclusion Criteria: * smoker or former smoker (\> 10 packs-year) * concomitant asthma exacerbation (at V1) * prisoners * protected adults * no affiliation to the French Social Security System
- Grenoble, France
- Pessac, France